Last reviewed · How we verify

NCT03102671

Effectiveness of the HeartHab Application on Exercise Capacity in Patients With Coronary Artery Disease

Completed NA Last updated 27 February 2018
What this trial tests

NA trial testing Use of HeartHab application followed by usual care in Coronary Artery Disease in 30 participants. Completed in 1 January 2018.

Timeline
1 March 2017
Primary endpoint
1 January 2018
1 January 2018

Quick facts

Lead sponsorHasselt University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeprevention
Enrollment30
Start date1 March 2017
Primary completion1 January 2018
Estimated completion1 January 2018
Sites1 location across Belgium

Drugs / interventions tested

Conditions studied

Sponsor

Hasselt University

Who can join

18 and older, any sex, with Coronary Artery Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The recurrence of major cardiac events after infarction is very high, in some populations up to 20% in the first year. Optimal secondary prevention as organized in cardiac rehabilitation centers is effective in reducing both morbidity and mortality. However, many studies have shown that the participation and adherence rate in CR-programs is low in most European countries. Therefore, novel ways of delivering secondary prevention using information technology and self-monitoring are being explored. Hence, this study will investigate the effectiveness of a mobile, patient tailored, app based multidisciplinary telerehabilitation program (HeartHab app) in improving exercise capacity, lifestyle and risk factors in patients with coronary artery disease in a post-rehabilitation setting.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Evaluating the Impact of the HeartHab App on Motivation, Physical Activity, Quality of Life, and Risk Factors of Coronary Artery Disease Patients: Multidisciplinary Crossover Study.
    Sankaran S, Dendale P, Coninx K. · · 2019 · cited 37× · PMID 30946021 · DOI 10.2196/10874
  2. The Recent Advances of Mobile Healthcare in Cardiology Practice.
    Kulbayeva S, Tazhibayeva K, Seiduanova L, Smagulova I, et al · · 2022 · cited 5× · PMID 36311150 · DOI 10.5455/aim.2022.30.236-250

Verify or expand the search:

Other recruiting trials for Coronary Artery Disease

Currently open trials in the same condition.

Other Hasselt University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03102671.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing